Reversing the Warburg effect as a treatment for glioblastoma.
about
Molecular Imaging of Metabolic Reprograming in Mutant IDH CellsTwo-way communication between the metabolic and cell cycle machineries: the molecular basisAlpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in gliomaMEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment.A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancerMitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cellsMethylene blue promotes quiescence of rat neural progenitor cells.Antitumor activity of a polypyridyl chelating ligand: in vitro and in vivo inhibition of glioma.Methylene blue protects astrocytes against glucose oxygen deprivation by improving cellular respiration.Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8.Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.Emerging metabolic targets in the therapy of hematological malignancies.Oxidative status predicts quality in human mesenchymal stem cells.Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders.Altered metabolic pathways in clear cell renal cell carcinoma: A meta-analysis and validation study focused on the deregulated genes and their associated networksIdentification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity.Autophagic flux in glioblastoma cells.Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming.2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner.Differential regulation of mitochondrial pyruvate carrier genes modulates respiratory capacity and stress tolerance in yeast.Development and Characterization of Methylene Blue Oleate Salt-Loaded Polymeric Nanoparticles and their Potential Application as a Treatment for Glioblastoma.Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.Pathway-based dissection of the genomic heterogeneity of cancer hallmarks' acquisition with SLAPenrich.
P2860
Q26750861-D6D9492F-42D9-42B4-A21E-E47283E573E0Q27013594-0C9F2116-102D-4698-B879-F28659B486E6Q28236366-280EB69E-E435-4101-9748-9C95E39BFFAEQ30278995-579779F5-3A19-4642-A643-D975DE1172BCQ33860823-9EDBAAD5-5C99-4D22-BC5F-4EF3EA571DF4Q34153501-4CF78C4A-9F49-48BB-A64F-843F1AE65C82Q34299731-77C1E3A2-7B94-4973-A597-EF32D3D73684Q35196720-48F85DF7-266D-4634-A57A-8B9854DA6369Q35596204-00C033FD-1B70-4095-BCC5-CAA184A01EF2Q36042582-934C59C8-5C14-450A-A602-A252BFC769D6Q36913723-F8041BDF-7B0D-49E7-BEEA-1B5DC06A2FD6Q37137623-A3C7B092-0D36-430A-8BDD-FBE58B019489Q37566969-7932A52A-2305-4D8D-A667-2036F220E230Q37617965-C580616E-85D4-4724-99FA-7ADF1CA2AC88Q37680586-C86EFF07-9162-4169-AF80-5B7D3D3DDEA6Q38467844-E80C13CF-577B-4AD1-A1C5-562BA68BF4D7Q38484441-FD043A55-F2A4-4EDA-AE11-F37775CE9C9DQ38765900-C49F55F2-1901-49B9-AE44-FB9BFD3A5863Q38787096-84F28538-6BBE-4299-8379-25A91226C220Q39174318-AE428268-2606-441D-BFC8-AF319E0C5850Q39202332-1494167D-3814-4DA8-BDA2-7FE5181EF826Q41287854-B0530FF2-7043-4F8E-8D1C-93A579AB0DDBQ41320019-D5D370A2-B3D8-4731-AA6F-AAECD881B1D3Q41974940-14EB982E-8F43-446B-A5D9-E5B9A2E4A808Q42374703-14CE7AAA-D981-4C99-8172-4669B57CD85CQ47710637-222C4B44-9C79-4292-8D3D-6D6131DDFAB1Q48662036-E3156721-F732-466C-91B4-47653D807545Q52678274-AA7DB4B0-5EB9-47F3-8853-AE74D96CC7BBQ55080794-0EA38BEA-9ECB-430E-8626-CB0BAE3E9444
P2860
Reversing the Warburg effect as a treatment for glioblastoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Reversing the Warburg effect as a treatment for glioblastoma.
@ast
Reversing the Warburg effect as a treatment for glioblastoma.
@en
type
label
Reversing the Warburg effect as a treatment for glioblastoma.
@ast
Reversing the Warburg effect as a treatment for glioblastoma.
@en
prefLabel
Reversing the Warburg effect as a treatment for glioblastoma.
@ast
Reversing the Warburg effect as a treatment for glioblastoma.
@en
P2093
P2860
P356
P1476
Reversing the Warburg effect as a treatment for glioblastoma.
@en
P2093
Ali Winters
Anuja Ghorpade
Ethan Poteet
Gourav Roy Choudhury
James W Simpkins
Myoung-Gwi Ryou
P2860
P304
P356
10.1074/JBC.M112.440354
P407
P577
2013-02-13T00:00:00Z